Ontario Industry Updates Guest User Ontario Industry Updates Guest User

Therapure Biomanufacturing Announces FDA Approval for Manufacturing of Insmed’s ARIKAYCE®

Therapure Biomanufacturing announced approval for the manufacturing of partner Insmed’s ARIKAYCE® at its Mississauga facility by the U.S. FDA. ARIKAYCE is the first and only treatment approved by the FDA specifically for patients with Mycobacterium avium complex lung disease, a chronic and debilitating condition that can significantly increase patient morbidity and mortality.

Read More
Ontario Industry Updates Guest User Ontario Industry Updates Guest User

Canada's Economic Strategy Tables Release Health and Biosciences Report

The report entitled “The Innovation and Competitiveness Imperative: Seizing Opportunities for Growth”, contains recommendations from six sectors with high growth potential, including the health and biosciences sector. The report outlined the roadmap to doubling the size of the health and biosciences sector and becoming a top-three global hub.

Read More